Global Injectable Sumatriptan Market Insights, Forecast to 2030

Publication ID:

PB512241218

Publication Date:

December 17, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Sumatriptan injection听comes as a solution (liquid) to inject subcutaneously (just under your skin). It is usually used at the first sign of a migraine headache. If your symptoms improve after you use听sumatriptan听but return after 1 hour or longer, you may use a second dose of听sumatriptan.
The global Injectable Sumatriptan market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Injectable Sumatriptan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Injectable Sumatriptan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Injectable Sumatriptan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Injectable Sumatriptan include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Injectable Sumatriptan, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Injectable Sumatriptan, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Injectable Sumatriptan, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Injectable Sumatriptan sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Injectable Sumatriptan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Injectable Sumatriptan sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Teva
Sun Pharma
Segment by Type
4mg
6mg
Others
Segment by Application
Hospitals
Clinics
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Injectable Sumatriptan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Injectable Sumatriptan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Sumatriptan sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Injectable Sumatriptan Product Introduction
1.2 Market by Type
1.2.1 Global Injectable Sumatriptan Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 4mg
1.2.3 6mg
1.2.4 Others
1.3 Market by Application
1.3.1 Global Injectable Sumatriptan Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Injectable Sumatriptan Sales Estimates and Forecasts 2019-2030
2.2 Global Injectable Sumatriptan Revenue by Region
2.2.1 Global Injectable Sumatriptan Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Injectable Sumatriptan Revenue by Region (2019-2024)
2.2.3 Global Injectable Sumatriptan Revenue by Region (2025-2030)
2.2.4 Global Injectable Sumatriptan Revenue Market Share by Region (2019-2030)
2.3 Global Injectable Sumatriptan Sales Estimates and Forecasts 2019-2030
2.4 Global Injectable Sumatriptan Sales by Region
2.4.1 Global Injectable Sumatriptan Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Injectable Sumatriptan Sales by Region (2019-2024)
2.4.3 Global Injectable Sumatriptan Sales by Region (2025-2030)
2.4.4 Global Injectable Sumatriptan Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Injectable Sumatriptan Sales by Manufacturers
3.1.1 Global Injectable Sumatriptan Sales by Manufacturers (2019-2024)
3.1.2 Global Injectable Sumatriptan Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Injectable Sumatriptan in 2023
3.2 Global Injectable Sumatriptan Revenue by Manufacturers
3.2.1 Global Injectable Sumatriptan Revenue by Manufacturers (2019-2024)
3.2.2 Global Injectable Sumatriptan Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Injectable Sumatriptan Revenue in 2023
3.3 Global Key Players of Injectable Sumatriptan, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Injectable Sumatriptan Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Injectable Sumatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Injectable Sumatriptan, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Injectable Sumatriptan, Product Offered and Application
3.8 Global Key Manufacturers of Injectable Sumatriptan, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Injectable Sumatriptan Sales by Type
4.1.1 Global Injectable Sumatriptan Historical Sales by Type (2019-2024)
4.1.2 Global Injectable Sumatriptan Forecasted Sales by Type (2025-2030)
4.1.3 Global Injectable Sumatriptan Sales Market Share by Type (2019-2030)
4.2 Global Injectable Sumatriptan Revenue by Type
4.2.1 Global Injectable Sumatriptan Historical Revenue by Type (2019-2024)
4.2.2 Global Injectable Sumatriptan Forecasted Revenue by Type (2025-2030)
4.2.3 Global Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Sumatriptan Price by Type
4.3.1 Global Injectable Sumatriptan Price by Type (2019-2024)
4.3.2 Global Injectable Sumatriptan Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Injectable Sumatriptan Sales by Application
5.1.1 Global Injectable Sumatriptan Historical Sales by Application (2019-2024)
5.1.2 Global Injectable Sumatriptan Forecasted Sales by Application (2025-2030)
5.1.3 Global Injectable Sumatriptan Sales Market Share by Application (2019-2030)
5.2 Global Injectable Sumatriptan Revenue by Application
5.2.1 Global Injectable Sumatriptan Historical Revenue by Application (2019-2024)
5.2.2 Global Injectable Sumatriptan Forecasted Revenue by Application (2025-2030)
5.2.3 Global Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Sumatriptan Price by Application
5.3.1 Global Injectable Sumatriptan Price by Application (2019-2024)
5.3.2 Global Injectable Sumatriptan Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Injectable Sumatriptan Market Size by Type
6.1.1 US & Canada Injectable Sumatriptan Sales by Type (2019-2030)
6.1.2 US & Canada Injectable Sumatriptan Revenue by Type (2019-2030)
6.2 US & Canada Injectable Sumatriptan Market Size by Application
6.2.1 US & Canada Injectable Sumatriptan Sales by Application (2019-2030)
6.2.2 US & Canada Injectable Sumatriptan Revenue by Application (2019-2030)
6.3 US & Canada Injectable Sumatriptan Market Size by Country
6.3.1 US & Canada Injectable Sumatriptan Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Injectable Sumatriptan Sales by Country (2019-2030)
6.3.3 US & Canada Injectable Sumatriptan Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Injectable Sumatriptan Market Size by Type
7.1.1 Europe Injectable Sumatriptan Sales by Type (2019-2030)
7.1.2 Europe Injectable Sumatriptan Revenue by Type (2019-2030)
7.2 Europe Injectable Sumatriptan Market Size by Application
7.2.1 Europe Injectable Sumatriptan Sales by Application (2019-2030)
7.2.2 Europe Injectable Sumatriptan Revenue by Application (2019-2030)
7.3 Europe Injectable Sumatriptan Market Size by Country
7.3.1 Europe Injectable Sumatriptan Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Injectable Sumatriptan Sales by Country (2019-2030)
7.3.3 Europe Injectable Sumatriptan Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Injectable Sumatriptan Market Size
8.1.1 China Injectable Sumatriptan Sales (2019-2030)
8.1.2 China Injectable Sumatriptan Revenue (2019-2030)
8.2 China Injectable Sumatriptan Market Size by Application
8.2.1 China Injectable Sumatriptan Sales by Application (2019-2030)
8.2.2 China Injectable Sumatriptan Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Injectable Sumatriptan Market Size by Type
9.1.1 Asia Injectable Sumatriptan Sales by Type (2019-2030)
9.1.2 Asia Injectable Sumatriptan Revenue by Type (2019-2030)
9.2 Asia Injectable Sumatriptan Market Size by Application
9.2.1 Asia Injectable Sumatriptan Sales by Application (2019-2030)
9.2.2 Asia Injectable Sumatriptan Revenue by Application (2019-2030)
9.3 Asia Injectable Sumatriptan Sales by Region
9.3.1 Asia Injectable Sumatriptan Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Injectable Sumatriptan Revenue by Region (2019-2030)
9.3.3 Asia Injectable Sumatriptan Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Injectable Sumatriptan Market Size by Type
10.1.1 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Injectable Sumatriptan Market Size by Application
10.2.1 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Country
10.3.1 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 GlaxoSmithKline Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Teva Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Company Information
11.4.2 Sun Pharma Overview
11.4.3 Sun Pharma Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sun Pharma Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Injectable Sumatriptan Industry Chain Analysis
12.2 Injectable Sumatriptan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Injectable Sumatriptan Production Mode & Process
12.4 Injectable Sumatriptan Sales and Marketing
12.4.1 Injectable Sumatriptan Sales Channels
12.4.2 Injectable Sumatriptan Distributors
12.5 Injectable Sumatriptan Customers
13 Market Dynamics
13.1 Injectable Sumatriptan Industry Trends
13.2 Injectable Sumatriptan Market Drivers
13.3 Injectable Sumatriptan Market Challenges
13.4 Injectable Sumatriptan Market Restraints
14 Key Findings in The Global Injectable Sumatriptan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

GlaxoSmithKline
Pfizer
Teva
Sun Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂